| Application | Recommended Dilution |
|---|---|
| IHC | 1:50-1:200 |
Complement receptor type 1, also known as CD35 or the C3b/C4b receptor, plays a central role in immune regulation by mediating the clearance of complement-opsonized particles and immune complexes from circulation. Expressed on erythrocytes, leukocytes, and various immune cell populations, CR1 serves as a critical modulator of complement activation and has become an important marker in studies of autoimmune disease, inflammation, and hematopoietic cell biology.
This recombinant monoclonal antibody, clone 4D4, offers researchers the reproducibility and consistency that comes with sequence-defined production. Unlike traditional hybridoma-derived antibodies, recombinant technology ensures that each lot performs identically to the last, eliminating the variability that can compromise longitudinal studies or multi-site collaborations. The rabbit host origin provides high affinity binding characteristics, while the monoclonal nature guarantees specificity for a single epitope on human CR1.
Validation in immunohistochemistry demonstrates reliable performance in paraffin-embedded human tonsil tissue, where the antibody was tested at 1:50 dilution using a standard citrate buffer antigen retrieval protocol. The tonsil represents an ideal validation tissue given its rich immune cell populations and known CR1 expression patterns. Researchers can expect effective staining within the recommended 1:50-1:200 dilution range, with flexibility to optimize based on their specific tissue types and detection systems.
Supplied in a glycerol-containing buffer for enhanced stability, this antibody is well-suited for immunology research programs investigating complement biology, immune complex disorders, or stem cell characterization where CR1 serves as a lineage marker. The ELISA-validated format also supports quantitative detection workflows.
Email: support@cusabio.com
Distributors Worldwide